 | • レポートコード：MRC2102QY14691 • 出版社/出版日： / 2021年1月 • レポート形態：英文、PDF、144ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥600,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥900,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,200,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| QYリサーチ社の本調査レポートでは、世界のテルミサルタン市場について種類別（注射、凍結乾燥粉末）、用途別（病院用、診療用、その他）、地域別（米国、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・テルミサルタン市場の概要 ・世界の主要地域別テルミサルタン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界のテルミサルタン市場規模2015-2026：種類別（注射、凍結乾燥粉末） ・世界のテルミサルタン市場規模2015-2026：用途別（病院用、診療用、その他） ・テルミサルタンの米国市場規模2015-2020 ・テルミサルタンのヨーロッパ市場規模2015-2020 ・テルミサルタンの中国市場規模2015-2020 ・テルミサルタンの日本市場規模2015-2020 ・テルミサルタンの東南アジア市場規模2015-2020 ・テルミサルタンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・テルミサルタンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・テルミサルタンの市場動向・機会・課題 ・調査の結論 |
Market Analysis and Insights: Global Telmisartan Market
The global Telmisartan market size is projected to reach US$ 3511.9 million by 2026, from US$ 3349.2 million in 2020, at a CAGR of 0.8% during 2021-2026.
Global Telmisartan Scope and Market Size
The global Telmisartan market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Telmisartan market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.
Segment by Type, the Telmisartan market is segmented into
Injection
Freeze-Dried Powder
Segment by Application, the Telmisartan market is segmented into
Hospital Use
Clinic Use
Others
The Telmisartan market is analysed and market size information is provided by regions (countries). Segment by Application, the Telmisartan market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.
Competitive Landscape and Telmisartan Market Share Analysis
Telmisartan market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Telmisartan business, the date to enter into the Telmisartan market, Telmisartan product introduction, recent developments, etc.
The major vendors covered:
Pfizer
Teva
Boehringer Ingelheim
Novartis
Mylan
Reddy’s Laboratories (UK)
Hema Pharmaceuticals Pvt
Bayer
GSK
Astellas Pharma Inc
Nippon Boehringer Ingelheim
Abbott
Takeda
Beijing Wansheng Pharmaceutical
1 Telmisartan Market Overview
1.1 Telmisartan Product Scope
1.2 Telmisartan Segment by Type
1.2.1 Global Telmisartan Sales by Type (2020-2026)
1.2.2 Injection
1.2.3 Freeze-Dried Powder
1.3 Telmisartan Segment by Application
1.3.1 Global Telmisartan Sales Comparison by Application (2020-2026)
1.3.2 Hospital Use
1.3.3 Clinic Use
1.3.4 Others
1.4 Telmisartan Market Estimates and Forecasts (2015-2026)
1.4.1 Global Telmisartan Sales Growth Rate (2015-2026)
1.4.2 Global Telmisartan Revenue and Growth Rate (2015-2026)
1.4.3 Global Telmisartan Price Trends (2015-2026)
2 Telmisartan Estimate and Forecast by Region
2.1 Global Telmisartan Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Telmisartan Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Telmisartan Sales Market Share by Region (2015-2020)
2.2.2 Global Telmisartan Revenue Market Share by Region (2015-2020)
2.3 Global Telmisartan Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Telmisartan Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Telmisartan Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Telmisartan Estimates and Projections (2015-2026)
2.4.2 Europe Telmisartan Estimates and Projections (2015-2026)
2.4.3 China Telmisartan Estimates and Projections (2015-2026)
2.4.4 Japan Telmisartan Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Telmisartan Estimates and Projections (2015-2026)
2.4.6 India Telmisartan Estimates and Projections (2015-2026)
3 Global Telmisartan Competition Landscape by Players
3.1 Global Top Telmisartan Players by Sales (2015-2020)
3.2 Global Top Telmisartan Players by Revenue (2015-2020)
3.3 Global Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)
3.4 Global Telmisartan Average Price by Company (2015-2020)
3.5 Manufacturers Telmisartan Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Telmisartan Players (Opinion Leaders)
4 Global Telmisartan Market Size by Type
4.1 Global Telmisartan Historic Market Review by Type (2015-2020)
4.1.1 Global Telmisartan Sales Market Share by Type (2015-2020)
4.1.2 Global Telmisartan Revenue Market Share by Type (2015-2020)
4.1.3 Global Telmisartan Price by Type (2015-2020)
4.2 Global Telmisartan Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Telmisartan Sales Forecast by Type (2021-2026)
4.2.2 Global Telmisartan Revenue Forecast by Type (2021-2026)
4.2.3 Global Telmisartan Price Forecast by Type (2021-2026)
5 Global Telmisartan Market Size by Application
5.1 Global Telmisartan Historic Market Review by Application (2015-2020)
5.1.1 Global Telmisartan Sales Market Share by Application (2015-2020)
5.1.2 Global Telmisartan Revenue Market Share by Application (2015-2020)
5.1.3 Global Telmisartan Price by Application (2015-2020)
5.2 Global Telmisartan Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Telmisartan Sales Forecast by Application (2021-2026)
5.2.2 Global Telmisartan Revenue Forecast by Application (2021-2026)
5.2.3 Global Telmisartan Price Forecast by Application (2021-2026)
6 United States Telmisartan Market Facts & Figures
6.1 United States Telmisartan Sales Market Share by Company (2015-2020)
6.2 United States Telmisartan Sales Market Share by Type (2015-2020)
6.3 United States Telmisartan Sales Market Share by Application (2015-2020)
7 Europe Telmisartan Market Facts & Figures
7.1 Europe Telmisartan Sales Market Share by Company (2015-2020)
7.2 Europe Telmisartan Sales Market Share by Type (2015-2020)
7.3 Europe Telmisartan Sales Market Share by Application (2015-2020)
8 China Telmisartan Market Facts & Figures
8.1 China Telmisartan Sales Market Share by Company (2015-2020)
8.2 China Telmisartan Sales Market Share by Type (2015-2020)
8.3 China Telmisartan Sales Market Share by Application (2015-2020)
9 Japan Telmisartan Market Facts & Figures
9.1 Japan Telmisartan Sales Market Share by Company (3015-3030)
9.2 Japan Telmisartan Sales Market Share by Type (2015-2020)
9.3 Japan Telmisartan Sales Market Share by Application (2015-2020)
10 Southeast Asia Telmisartan Market Facts & Figures
10.1 Southeast Asia Telmisartan Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Telmisartan Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Telmisartan Sales Market Share by Application (2015-2020)
11 India Telmisartan Market Facts & Figures
11.1 India Telmisartan Sales Market Share by Company (2015-2020)
11.2 India Telmisartan Sales Market Share by Type (2015-2020)
11.3 India Telmisartan Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Telmisartan Business
12.1 Pfizer
12.1.1 Pfizer Corporation Information
12.1.2 Pfizer Business Overview
12.1.3 Pfizer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Pfizer Telmisartan Products Offered
12.1.5 Pfizer Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Telmisartan Products Offered
12.2.5 Teva Recent Development
12.3 Boehringer Ingelheim
12.3.1 Boehringer Ingelheim Corporation Information
12.3.2 Boehringer Ingelheim Business Overview
12.3.3 Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Boehringer Ingelheim Telmisartan Products Offered
12.3.5 Boehringer Ingelheim Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Telmisartan Products Offered
12.4.5 Novartis Recent Development
12.5 Mylan
12.5.1 Mylan Corporation Information
12.5.2 Mylan Business Overview
12.5.3 Mylan Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Mylan Telmisartan Products Offered
12.5.5 Mylan Recent Development
12.6 Reddy’s Laboratories (UK)
12.6.1 Reddy’s Laboratories (UK) Corporation Information
12.6.2 Reddy’s Laboratories (UK) Business Overview
12.6.3 Reddy’s Laboratories (UK) Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Reddy’s Laboratories (UK) Telmisartan Products Offered
12.6.5 Reddy’s Laboratories (UK) Recent Development
12.7 Hema Pharmaceuticals Pvt
12.7.1 Hema Pharmaceuticals Pvt Corporation Information
12.7.2 Hema Pharmaceuticals Pvt Business Overview
12.7.3 Hema Pharmaceuticals Pvt Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Hema Pharmaceuticals Pvt Telmisartan Products Offered
12.7.5 Hema Pharmaceuticals Pvt Recent Development
12.8 Bayer
12.8.1 Bayer Corporation Information
12.8.2 Bayer Business Overview
12.8.3 Bayer Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Bayer Telmisartan Products Offered
12.8.5 Bayer Recent Development
12.9 GSK
12.9.1 GSK Corporation Information
12.9.2 GSK Business Overview
12.9.3 GSK Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.9.4 GSK Telmisartan Products Offered
12.9.5 GSK Recent Development
12.10 Astellas Pharma Inc
12.10.1 Astellas Pharma Inc Corporation Information
12.10.2 Astellas Pharma Inc Business Overview
12.10.3 Astellas Pharma Inc Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Astellas Pharma Inc Telmisartan Products Offered
12.10.5 Astellas Pharma Inc Recent Development
12.11 Nippon Boehringer Ingelheim
12.11.1 Nippon Boehringer Ingelheim Corporation Information
12.11.2 Nippon Boehringer Ingelheim Business Overview
12.11.3 Nippon Boehringer Ingelheim Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Nippon Boehringer Ingelheim Telmisartan Products Offered
12.11.5 Nippon Boehringer Ingelheim Recent Development
12.12 Abbott
12.12.1 Abbott Corporation Information
12.12.2 Abbott Business Overview
12.12.3 Abbott Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Abbott Telmisartan Products Offered
12.12.5 Abbott Recent Development
12.13 Takeda
12.13.1 Takeda Corporation Information
12.13.2 Takeda Business Overview
12.13.3 Takeda Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Takeda Telmisartan Products Offered
12.13.5 Takeda Recent Development
12.14 Beijing Wansheng Pharmaceutical
12.14.1 Beijing Wansheng Pharmaceutical Corporation Information
12.14.2 Beijing Wansheng Pharmaceutical Business Overview
12.14.3 Beijing Wansheng Pharmaceutical Telmisartan Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Beijing Wansheng Pharmaceutical Telmisartan Products Offered
12.14.5 Beijing Wansheng Pharmaceutical Recent Development
13 Telmisartan Manufacturing Cost Analysis
13.1 Telmisartan Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Telmisartan
13.4 Telmisartan Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Telmisartan Distributors List
14.3 Telmisartan Customers
15 Market Dynamics
15.1 Telmisartan Market Trends
15.2 Telmisartan Opportunities and Drivers
15.3 Telmisartan Market Challenges
15.4 Telmisartan Market Restraints
15.5 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Telmisartan Sales (MT) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Telmisartan Sales (MT) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Telmisartan Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Telmisartan Sales (MT) by Region (2015-2020)
Table 5. Global Telmisartan Sales Market Share by Region (2015-2020)
Table 6. Global Telmisartan Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Telmisartan Revenue Share by Region (2015-2020)
Table 8. Global Telmisartan Sales (MT) Forecast by Region (2021-2026)
Table 9. Global Telmisartan Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Telmisartan Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Telmisartan Revenue Share Forecast by Region (2021-2026)
Table 12. Global Telmisartan (MT) of Key Companies (2015-2020)
Table 13. Global Telmisartan Sales Share by Company (2015-2020)
Table 14. Global Telmisartan Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Telmisartan Revenue Share by Company (2015-2020)
Table 16. Global Telmisartan by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Telmisartan as of 2019)
Table 17. Global Telmisartan Average Price (USD/Kg) of Key Company (2015-2020)
Table 18. Manufacturers Telmisartan Manufacturing Sites and Area Served
Table 19. Manufacturers Telmisartan Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Telmisartan Players
Table 22. Global Telmisartan Sales (MT) by Type (2015-2020)
Table 23. Global Telmisartan Sales Share by Type (2015-2020)
Table 24. Global Telmisartan Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Telmisartan Price (MT) by Type (2015-2020)
Table 26. Global Telmisartan Sales Share by Type (2021-2026)
Table 27. Global Telmisartan Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Telmisartan Revenue Share by Type (2021-2026)
Table 29. Global Telmisartan Price (MT) by Type (2021-2026)
Table 30. Global Telmisartan Sales (MT) by Application (2015-2020)
Table 31. Global Telmisartan Sales Share by Application (2015-2020)
Table 32. Global Telmisartan Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Telmisartan Price (MT) by Application (2015-2020)
Table 34. Global Telmisartan Sales (MT) by Application (2021-2026)
Table 35. Global Telmisartan Sales Share by Application (2021-2026)
Table 36. Global Telmisartan Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Telmisartan Revenue Share by Application (2021-2026)
Table 38. Global Telmisartan Price (MT) by Application (2021-2026)
Table 39. United States Telmisartan Sales (MT) by Company (2015-2020)
Table 40. United States Telmisartan Sales Market Share by Company (2015-2020)
Table 41. United States Telmisartan Sales (MT) by Type (2015-2020)
Table 42. United States Telmisartan Sales Market Share by Type (2015-2020)
Table 43. United States Telmisartan Sales (MT) by Application (2015-2020)
Table 44. United States Telmisartan Sales Market Share by Application (2015-2020)
Table 45. Europe Telmisartan Sales (MT) by Company (2015-2020)
Table 46. Europe Telmisartan Sales Market Share by Company (2015-2020)
Table 47. Europe Telmisartan Sales (MT) by Type (2015-2020)
Table 48. Europe Telmisartan Sales Market Share by Type (2015-2020)
Table 49. Europe Telmisartan Sales (MT) by Application (2015-2020)
Table 50. Europe Telmisartan Sales Market Share by Type (2015-2020)
Table 51. China Telmisartan Sales (MT) by Company (2015-2020)
Table 52. China Telmisartan Sales Market Share by Company (2015-2020)
Table 53. China Telmisartan Sales (MT) by Type (2015-2020)
Table 54. China Telmisartan Sales Market Share by Type (2015-2020)
Table 55. China Telmisartan Sales (MT) by Application (2015-2020)
Table 56. China Telmisartan Sales Market Share by Application (2015-2020)
Table 57. Japan Telmisartan Sales (MT) by Company (2015-2020)
Table 58. Japan Telmisartan Sales Market Share by Company (2015-2020)
Table 59. Japan Telmisartan Sales (MT) by Type (2015-2020)
Table 60. Japan Telmisartan Sales Market Share by Type (2015-2020)
Table 61. Japan Telmisartan Sales (MT) by Application (2015-2020)
Table 62. Japan Telmisartan Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Telmisartan Sales (MT) by Company (2015-2020)
Table 64. Southeast Asia Telmisartan Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Telmisartan Sales (MT) by Type (2015-2020)
Table 66. Southeast Asia Telmisartan Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Telmisartan Sales (MT) by Type (2015-2020)
Table 68. Southeast Asia Telmisartan Sales Market Share by Application (2015-2020)
Table 69. India Telmisartan Sales (MT) by Company (2015-2020)
Table 70. India Telmisartan Sales Market Share by Company (2015-2020)
Table 71. India Telmisartan Sales (MT) by Type (2015-2020)
Table 72. India Telmisartan Sales Market Share by Type (2015-2020)
Table 73. India Telmisartan Sales (MT) by Application (2015-2020)
Table 74. India Telmisartan Sales Market Share by Application (2015-2020)
Table 75. Pfizer Corporation Information
Table 76. Pfizer Description and Business Overview
Table 77. Pfizer Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 78. Pfizer Telmisartan Product
Table 79. Pfizer Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 83. Teva Telmisartan Product
Table 84. Teva Recent Development
Table 85. Boehringer Ingelheim Corporation Information
Table 86. Boehringer Ingelheim Description and Business Overview
Table 87. Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 88. Boehringer Ingelheim Telmisartan Product
Table 89. Boehringer Ingelheim Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 93. Novartis Telmisartan Product
Table 94. Novartis Recent Development
Table 95. Mylan Corporation Information
Table 96. Mylan Description and Business Overview
Table 97. Mylan Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 98. Mylan Telmisartan Product
Table 99. Mylan Recent Development
Table 100. Reddy's Laboratories (UK) Corporation Information
Table 101. Reddy's Laboratories (UK) Description and Business Overview
Table 102. Reddy's Laboratories (UK) Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 103. Reddy's Laboratories (UK) Telmisartan Product
Table 104. Reddy's Laboratories (UK) Recent Development
Table 105. Hema Pharmaceuticals Pvt Corporation Information
Table 106. Hema Pharmaceuticals Pvt Description and Business Overview
Table 107. Hema Pharmaceuticals Pvt Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 108. Hema Pharmaceuticals Pvt Telmisartan Product
Table 109. Hema Pharmaceuticals Pvt Recent Development
Table 110. Bayer Corporation Information
Table 111. Bayer Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 112. Bayer Description and Business Overview
Table 113. Bayer Telmisartan Product
Table 114. Bayer Recent Development
Table 115. GSK Corporation Information
Table 116. GSK Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 117. GSK Description and Business Overview
Table 118. GSK Telmisartan Product
Table 119. GSK Recent Development
Table 120. Astellas Pharma Inc Corporation Information
Table 121. Astellas Pharma Inc Description and Business Overview
Table 122. Astellas Pharma Inc Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 123. Astellas Pharma Inc Telmisartan Product
Table 124. Astellas Pharma Inc Recent Development
Table 125. Nippon Boehringer Ingelheim Corporation Information
Table 126. Nippon Boehringer Ingelheim Description and Business Overview
Table 127. Nippon Boehringer Ingelheim Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 128. Nippon Boehringer Ingelheim Telmisartan Product
Table 129. Nippon Boehringer Ingelheim Recent Development
Table 130. Abbott Corporation Information
Table 131. Abbott Description and Business Overview
Table 132. Abbott Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 133. Abbott Telmisartan Product
Table 134. Abbott Recent Development
Table 135. Takeda Corporation Information
Table 136. Takeda Description and Business Overview
Table 137. Takeda Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 138. Takeda Telmisartan Product
Table 139. Takeda Recent Development
Table 140. Beijing Wansheng Pharmaceutical Corporation Information
Table 141. Beijing Wansheng Pharmaceutical Description and Business Overview
Table 142. Beijing Wansheng Pharmaceutical Telmisartan Sales (MT), Revenue (Million USD), Price (USD/Kg) and Gross Margin (2015-2020)
Table 143. Beijing Wansheng Pharmaceutical Telmisartan Product
Table 144. Beijing Wansheng Pharmaceutical Recent Development
Table 145. Production Base and Market Concentration Rate of Raw Material
Table 146. Key Suppliers of Raw Materials
Table 147. Telmisartan Distributors List
Table 148. Telmisartan Customers List
Table 149. Telmisartan Market Key Trends
Table 150. Telmisartan Key Opportunities and Drivers
Table 151. Telmisartan Market Challenges
Table 152. Research Programs/Design for This Report
Table 153. Key Data Information from Secondary Sources
Table 154. Key Data Information from Primary Sources
List of Figures
Figure 1. Telmisartan Product Picture
Figure 2. Global Telmisartan Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Telmisartan Market Share by Application in 2020 & 2026
Figure 6. Hospital Use Examples
Figure 7. Clinic Use Examples
Figure 8. Others Examples
Figure 9. Global Telmisartan Sales (MT) Growth Rate (2015-2026)
Figure 10. Global Telmisartan Revenue (US$ Million) Growth Rate (2015-2026)
Figure 11. Global Telmisartan Price Trends Growth Rate (2015-2026) (USD/Kg)
Figure 12. Global Telmisartan Revenue Market Share by Region: 2015 VS 2020
Figure 13. Global Telmisartan Revenue Market Share by Region: 2021 VS 2026
Figure 14. United States Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 15. United States Telmisartan Sales (MT) Growth Rate (2015-2026)
Figure 16. Europe Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 17. Europe Telmisartan Sales (Million USD) Growth Rate (2015-2026)
Figure 18. China Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 19. China Telmisartan Sales (Million USD) and Growth Rate (2015-2026)
Figure 20. Japan Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 21. Japan Telmisartan Sales (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Telmisartan Sales (Million USD) Growth Rate (2015-2026)
Figure 24. India Telmisartan Revenue (Million USD) Growth Rate (2015-2026)
Figure 25. India Telmisartan Sales (Million USD) Growth Rate (2015-2026)
Figure 26. Global 5 Largest Telmisartan Players Market Share by Revenue in Telmisartan 2015 & 2019
Figure 27. Telmisartan Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 28. Global Telmisartan Revenue Share by Type (2015-2020)
Figure 29. Global Telmisartan Revenue Growth Rate by Type in 2015 & 2019
Figure 30. Global Telmisartan Revenue Share by Application (2015-2020)
Figure 31. Global Telmisartan Revenue Growth Rate by Application in 2015 & 2019
Figure 32. United States Telmisartan Sales Market Share by Type in 2019
Figure 33. United States Telmisartan Sales Market Share by Type in 2019
Figure 34. Europe Telmisartan Sales Market Share by Company in 2019
Figure 35. Europe Telmisartan Sales Market Share by Type in 2019
Figure 36. Europe Telmisartan Sales Market Share by Application in 2019
Figure 37. China Telmisartan Sales Market Share by Company in 2019
Figure 38. China Telmisartan Sales Market Share by Type in 2019
Figure 39. China Telmisartan Sales Market Share by Application in 2019
Figure 40. Japan Telmisartan Sales Market Share by Company in 2019
Figure 41. Japan Telmisartan Sales Market Share by Type in 2019
Figure 42. Japan Telmisartan Sales Market Share by Application in 2019
Figure 43. Southeast Asia Telmisartan Sales Market Share by Company in 2019
Figure 44. Southeast Asia Telmisartan Sales Market Share by Type in 2019
Figure 45. Southeast Asia Telmisartan Sales Market Share by Application in 2019
Figure 46. India Telmisartan Sales Market Share by Company in 2019
Figure 47. India Telmisartan Sales Market Share by Type in 2019
Figure 48. India Telmisartan Sales Market Share by Application in 2019
Figure 49. Key Raw Materials Price Trend
Figure 50. Manufacturing Cost Structure of Telmisartan
Figure 51. Manufacturing Process Analysis of Telmisartan
Figure 52. Telmisartan Industrial Chain Analysis
Figure 53. Channels of Distribution
Figure 54. Distributors Profiles
Figure 55. Porter's Five Forces Analysis
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed
注射オキシトシンの世界市場レポート2020 Market Analysis and Insights: Global Injection Oxytocin Market The global Injection Oxytocin market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Injection Oxytocin Scope and Market Size The global Injection Oxytocin market …- 乾燥素麺の世界市場レポート2020 Market Analysis and Insights: Global Fine Dried Noodles Market The global Fine Dried Noodles market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Fine Dried Noodles Scope and Market Size The global Fine Dried Noodles market …
- 乾燥肉の世界市場レポート2020 Market Analysis and Insights: Global Dried Meats Market The global Dried Meats market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX% during 2021-2026. Global Dried Meats Scope and Market Size The global Dried Meats market is segmented by company, reg…
- 凍結乾燥器の世界市場レポート2020 A freeze dryer executes a water removal process typically used to preserve perishable materials, to extend shelf life or make the material more convenient for transport. Freeze dryers work by freezing the material, then reducing the pressure and adding heat to allow the frozen water in the material …
- インスリン注射ペンの世界市場レポート2020 Market Analysis and Insights: Global Insulin Injection Pen Market The global Insulin Injection Pen market size is projected to reach US$ 7050.6 million by 2026, from US$ 3713 million in 2020, at a CAGR of 11.3% during 2021-2026. Global Insulin Injection Pen Scope and Market Size The global Insulin I…